Effect of RG 12525, a new leukotriene antagonist, on pulmonary function of asthmatic adultsWELCH, M. J; NELSON, H. S; PAULL, B. R et al.Annals of allergy. 1994, Vol 72, Num 4, pp 348-352, issn 0003-4738Conference Paper

Preparation and characterization of polymorphs for an LTD₄ antagonist, RG 12525CARLTON, R. A; DIFEO, T. J; POWNER, T. H et al.Journal of pharmaceutical sciences. 1996, Vol 85, Num 5, pp 461-467, issn 0022-3549Article

Effect of RG 12525, an oral leukotriene D₄ antagonist, on the airway response to inhaled leukotriene D₄ in subjects with mild asthmaWAHEDNA, I; WISNIEWSKI, A. S; TATTERSFIELD, A. E et al.British journal of clinical pharmacology. 1991, Vol 32, Num 4, pp 512-515, issn 0306-5251Article

Subchronic toxicity studies with the leukotriene D₄ antagonist RG 12525BONNEFOI, M. S; KELLEY, M. F; WELLS, R. E et al.Fundamental and applied toxicology (Print). 1995, Vol 28, Num 1, pp 129-138, issn 0272-0590Article

Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-γ agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activityFAYER, Jessica L; ZANNIKOS, Peter N; STEVENS, Jeffrey C et al.Journal of clinical pharmacology. 2001, Vol 41, Num 3, pp 305-316, issn 0091-2700Article

Antagonism of peptidoleukotrienes and inhibition of systemic anaphylaxis by RG 12525 in guinea pigsVAN INWEGEN, R. G; NUSS, G. W; CARNATHAN, G. W et al.Life sciences (1973). 1989, Vol 44, Num 12, pp 799-807, issn 0024-3205Article

Characterization of 2-[[4-[[2-(1h-tetrazol-5-ylmethyl)phenyl]methoxy]phenoxy]methyl]quinoline N-glucuronidation by in vitro and in vivo approachesSTEVENS, Jeffrey C; FAYER, Jessica L; CASSIDY, Kenneth C et al.Drug metabolism and disposition. 2001, Vol 29, Num 3, pp 289-295, issn 0090-9556Article